Mitsubishi Tanabe hit by more recall woes
This article was originally published in Scrip
Executive Summary
Japan's Mitsubishi Tanabe Pharma (MTP) has been hit again by concerns over its quality assurance procedures after it admitted that certain required tests were not performed on some lots of injected products before their release into the market.